
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : VLS-1488
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Sponsor : Volastra Therapeutics
Deal Size : Undisclosed
Deal Type : Partnership
Function Oncology Partners with Volastra Therapeutics for Precision Medicine
Details : The collaboration combines Function's CRISPR-enabled genomics with Volastra’s expertise in CIN to expand patient selection for Volastra’s KIF18A inhibitors, including VLS-1488, in solid tumors.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
March 26, 2024
Lead Product(s) : VLS-1488
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Sponsor : Volastra Therapeutics
Deal Size : Undisclosed
Deal Type : Partnership
